DEC 10, 2019 3:03 PM PST

T Cell Subset Uniquely Equipped to Target IBD

WRITTEN BY: Kara Marker

A specialized form of T cell emerges as a new focus for gastrointestinal (GI) health research, specifically in the context of inflammatory bowel disease (IBD) for children. In a new Canadian study, researchers observe how this T cell subtype is uniquely able to suppress IBD-related inflammation.

The specialized T cells are called Tr1 cells, and they appear to play an important role in repairing the GI tract barrier with chemical signaling. The GI tract is often damaged as a result of IBD pathology, and Tr1 cells support GI health by stimulating the production of protective mucus.

"As a new therapy, Tr1 cells could both suppress the inflammation that is ravaging the lining of the gut and help heal the tissue lining that keeps out harmful bacteria,” explained senior author Megan Levings, PhD.

This is good news for the seven thousand children diagnosed with IBD in Canada alone, with Tr1 cells a potential new therapeutic target to address this condition. Researchers investigated the interaction between Tr1 cells and other body cells with an experimental model of “self-organized, three-dimensional mini-guts.” Researchers observed Tr1 cells supporting the GI health of these mini guts by stimulating protective mucus release and generally promoting local GI environmental health.

IBD is an inflammatory condition of the GI tract that includes both Crohn’s disease and ulcerative colitis. People with IBD often experience chronically recurring episodes. The disease is also associated with an increased risk of colon cancer.

People with IBD experience symptoms such as abdominal pain, diarrhea, and vomiting that lead to more serious conditions of malnutrition, weight loss, fatigue and – ultimately – poor quality of life. The classic pharmaceutical therapeutic approach relies on antibody-based treatments that suppress inflammation. However, at least one-third of IBD patients either do not respond completely to the treatment or they do not respond at all.

Scientists have yet to understand why IBD develops in the first place with Tr1 cells on the scene, but it could simply be that there are not enough Tr1 cells to prevent the condition from developing. More research studies in the future could expand the understanding of this relationship.

Sources: University of British Columbia, Gastroenterology, Annual Review of Immunology

About the Author
I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
FEB 01, 2022
Immunology
Good Brain Tumor Drugs Come In Small Packages
FEB 01, 2022
Good Brain Tumor Drugs Come In Small Packages
  It isn’t easy to wrap the head around just how tiny nanoparticles are—a billionth of a meter in diame ...
FEB 28, 2022
Plants & Animals
Fecal Microbiota Transplant Promising for Peanut Allergy Patients
FEB 28, 2022
Fecal Microbiota Transplant Promising for Peanut Allergy Patients
Peanut allergies can be fatal, leading to severe allergic reactions that can restrict breathing and digestive problems, ...
MAR 22, 2022
Health & Medicine
Back to Nature: the Health Benefits of Nature Prescriptions
MAR 22, 2022
Back to Nature: the Health Benefits of Nature Prescriptions
With modern amenities and luxuries, it's easy to be unaware of just how much we may neglect the outdoors and its hea ...
APR 21, 2022
Health & Medicine
Inhibiting a Key Signaling Pathway in Immune Cells Slows Alzheimer's Progression
APR 21, 2022
Inhibiting a Key Signaling Pathway in Immune Cells Slows Alzheimer's Progression
Weill Cornell Medicine researchers recently discovered that inhibiting a key signaling pathway in brain cells can lessen ...
MAY 15, 2022
Health & Medicine
Virus-Infected Pig Heart Transplanted Into a Human
MAY 15, 2022
Virus-Infected Pig Heart Transplanted Into a Human
The University of Maryland School of Medicine reached a medical milestone this year when it transplanted a genetically-e ...
MAY 18, 2022
Immunology
COVID-19, MIS-C & Kawasaki Disease Lead to the Same Immune Response
MAY 18, 2022
COVID-19, MIS-C & Kawasaki Disease Lead to the Same Immune Response
The world has quickly learned that the SARS-CoV-2 virus causes COVID-19. But it can also cause another disorder in child ...
Loading Comments...